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Biome
sity of
ox.ac.uAbstract—The delivery of genes into cells through the transfer of ribonucleic acids (RNAs) has been found to cause
a change in the level of target protein expression. RNA-based transfection is conceptually more efficient than
commonly delivered plasmid DNA because it does not require division or damage of the nuclear envelope, thereby
increasing the chances of the cell remaining viable. Shock waves (SWs) have been found to induce cellular uptake
by transiently altering the permeability of the plasma membrane, thereby overcoming a critical step in gene ther-
apy. However, accompanying SWbio-effects include dose-dependent irreversible cell injury and cytotoxicity. Here,
the effect of SWs generated by a clinical lithotripter on the viability and permeabilisation of three different cell
lines in vitro was investigated. Comparison of RNA stability before and after SWexposure revealed no statistically
significant difference. Optimal SWexposure parameters were identified to minimise cell death and maximise per-
meabilisation, and applied to enhanced green fluorescent protein (eGFP) messenger RNA (mRNA) or anti-eGFP
small interfering RNA delivery. As a result, eGFP mRNA expression levels increased up to 52-fold in CT26 cells,
whereas a 2-fold decrease in GFP expression was achieved after anti-eGFP small interfering RNA delivery to
MCF-7/GFP cells. These results indicate that SW parameters can be employed to achieve effective nucleotide de-
livery, laying the foundation for non-invasive and high-tolerability RNA-based gene therapy. (E-mail: sandra.
nwokeoha@eng.ox.ac.uk)  2016 The Authors. Published by Elsevier Inc. on behalf of World Federation for
Ultrasound in Medicine & Biology. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
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Nucleic acid–based therapies provide a powerful approach
to the treatment of genetic diseases, by introducing into
target cells, healthy replacements of mutated or absent
genes, or gene-specific inhibitory molecules; ultimately
to reinstate typical cellular function either through the
expression of normal protein or the repression of defective
protein. However, biological and chemical vectors for
delivery are limited by potential viral toxicity and poor
targeting, respectively (Mehier-Humbert and Guy 2005).
On the other hand, physical transfection systems for the
delivery of nucleic acids have attracted substantial
attention in recent years, as they permit accessibility toddress correspondence to: Sandra Nwokeoha, Institute of
dical Engineering, Old Road Campus Research Building, Univer-
Oxford, OX3 7DQ, Oxford, UK. E-mail: sandra.nwokeoha@eng.
k
2478the target site and entry into the cell’s cytosol.
Such methods include electroporation, the gene gun,
laser irradiation, magnetofection and microinjection.
Notably, electroporation has achieved comparably high
transfection levels, whereby up to 1000-fold increases in
gene expression have been reported relative to the
admittedly highly inefficient level achieved with standard
plasmid DNA injection (Wells 2004). However, one
common drawback all such methods share is the inability
to access deep-seated tissues without compromising
safety. As a result, sonoporation, the process of
transiently permeabilising the cell membrane using
ultrasound, provides the most practical and least invasive
device-based option when deep access is needed
(Mo et al. 2012). Nonetheless, the efficacy of sonoporation
strongly depends on the acoustic parameters of the
employed technology, because a trade-off exists between
maintaining high cell viability and achieving nucleotide
uptake.
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more than 30 years to fragment kidney stones extracorpo-
really (Chaussy et al. 1980; Cleveland and McAteer
2007), with later applications in macromolecule (Delius
and Adams 1999; Gambihler et al. 1994) and plasmid
DNA transfer into tumours (Bao et al. 1998; Miller
et al. 1999; Song et al. 2002) and chondrocytes in vitro
(Murata et al. 2007). Lithotripter-generated shock waves
are characterized as high-amplitude short-pulse acoustic
waves that exert mechanical forces on the focal zone,
through two known mechanisms: direct shear stress and
the formation, growth and subsequent violent collapse
of cavitation bubbles (Cleveland and McAteer 2007;
Madersbacher and Marberger 2003). Transfer has been
attributed to a transient disruption of the plasma
membrane taking the shape of defects or pores at least
50 nm in diameter (Ben-Dor et al. 2000). The short dura-
tion of the shock wave pulse results in a temperature rise
,1C, producing negligible thermal effects (Huber et al.
1999). This aspect favours shock wave-assisted gene
therapy over high-intensity focused ultrasound, as the
latter results in tissue heating that may damage the cells,
thereby compromising viability, which is a prerequisite
for gene expression, as well as potentially affecting the
functionality of the delivered nucleotide.
Awide range of shock wave-induced DNA transfec-
tion efficiencies has been reported in vitro. Lauer et al.
(1997) observed poor permeabilisation levels of between
0.1% and 0.5%, which were found to be independent of
the cell concentration utilised. Huber et al. (1999) opti-
mised their shock wave exposure of cells and determined
a threefold stimulation enhancement of reporter gene
expression. The introduction of cavitation nuclei was
deemed necessary for robust shock wave effects by
Miller et al. (1999) and was achieved by intentionally
having residual air in their cell samples. More recently,
Millan-Chiu et al. (2014) reported that a maximum of
2.9% of cells exposed to shock waves were transfected
based on refined but suboptimal parameter settings. In
contrast, Bao et al. (1998) found that at 50% cell viability,
cells exposed to 200 shock waves had a 50-fold increase
in reporter gene expression per million cells.
The introduction of nucleotide into the cell as DNA
has seen faster research uptake compared with RNA
because of its inherent stability. In contrast, RNA is labile
and more difficult to synthesise. Nonetheless, mRNA
provides greater reliability of transfection because it
does not require nuclear entry for protein expression
and, thus, is not limited to cycling cells (Bettinger et al.
2001; Gilboa and Vieweg 2004). As such, host genome
integration and risk of insertion-based mutagenesis are
averted (Pinel et al. 2014). Moreover, mRNA promotes
relatively faster reporter gene production, as the initial
transcription phase in gene expression is foregone(Ponsaerts et al. 2003). Furthermore, unlike DNA,
mRNA is free from immunogenic CpG motifs that may
elicit host immune response (Pinel et al. 2014).
For the reduced translation of aberrant cellular
protein, small interfering RNA (siRNA), which also has
a cytoplasmic site of action, has been reported to achieve
effective gene knockdown (Bertrand et al. 2002) through
the command of sequence-complementary mRNA
degradation (Hall 2004). As such, siRNA holds promise
in the treatment of oncogenes and other disorder-
generating gene products. Hence, RNA may be
particularly suited to delivery by lithotripsy because,
provided the right parameters can be identified, opening
of the plasma membrane may be achieved without
needing to impart damage to the nucleus.
To date, shock waves have not yet been exploited for
mRNA-based transgene expression, and in the context of
in vitro studies, the application of tissue-mimicking mate-
rials (TMMs) has been scarce. Similarly, there are few
reports of shock wave-induced siRNA delivery in the
literature. In addition, studies detailing shock wave
dose-dependent bio-effects were performed using
early-generation technologies (reviewed in Br€ummer
et al. 1990), with a considerable number of studies using
such machines as the Dornier XL1 lithotripter (Br€ummer
et al. 1989; Delius and Adams 1999; Gambihler et al.
1994; Lauer et al. 1997) and the Siemens Lithostar
(Huber et al. 1999; Oosterhof et al. 1989), which are no
longer available. In view of newer clinical lithotripter
technology, which provides an enabling pathway to
translation, little, if any, work has been conducted on
shock wave-mediated cancer treatment at the cellular
level.
Here, we present studies aimed at achieving and
describing delivery of RNA to cells using a state-of-
the-art clinical shock wave source. We report cell
line-based optimal shock wave parameters for the
enhancement of RNA transfection of cancer cells.METHODS
Cell lines and cell culture
Mouse colorectal carcinoma CT26.WT cells
(ATCC, CRL-2638; American Type Culture Collection,
Rockville, MD, USA), kindly provided by the Depart-
ment of Oncology (Oxford University, Oxford, UK),
were grown in Roswell Park Memorial Institute
(RPMI)-1640 medium (Sigma-Aldrich, St. Louis, MO,
USA) supplemented with 10% fetal bovine serum
(FBS, Thermo Fisher Scientific, Waltham, MA, USA),
in a humidified atmosphere containing 5% CO2, at
37C. Cells were grown to a minimum of 90%
confluence and $95% cell viability for use in shock
wave experiments. Cells were washed with Dulbecco’s
2480 Ultrasound in Medicine and Biology Volume 42, Number 10, 2016phosphate-buffered saline solution (Thermo Fisher
Scientific), harvested by brief trypsinisation and
neutralised with medium twice the volume of the
trypsin–EDTA (Thermo Fisher Scientific). A cell pellet
was formed by centrifugation at 300g for 5 min and
re-suspended in serum-containing medium. To ensure
cell density and homogeneity, the prepared cell
suspension was agitated using a vortex mixer for a few
seconds before counting. Total cell counting was
performed using the trypan blue (Thermo Fisher
Scientific) dye exclusion method and a haemocytometer.
A cell stock solution was then prepared by extracting the
total number of cells required from the cell suspension
and diluting with medium to the total required volume.
The stock solution was spun once more before dispensing
into sample units.
Two other cell lines were similarly cultured: immor-
talised human kidney (HK-2) cells (ATCC, CRL-2190)
and human breast cancer (MCF-7) cells stably expressing
green fluorescent protein (GFP, AKR-211, Cell Biolabs,
San Diego, CA, USA). These were treated using 10%
fetal bovine serum–supplemented Dulbecco’s modified
Eagle medium (Thermo Fisher Scientific) in lieu of
RPMI-1640.Shock wave generation and setup
Shock waves were generated with the Storz
Modulith SLX-F2 lithotripter (Storz Medical, Kreuzlin-
gen, Switzerland) with the kind permission of Oxford
Stone Group (Churchill Hospital, Oxford, UK). The
lithotripter consisted of an electromagnetic cylinder coil
with dual focal zones. The wide focus zone was applied
to all experiments, with a nominal size of 9 3 50 mm
(diameter 3 length) at peak positive pressures ranging
from 5 to 90 MPa. Experiments were carried out in aFig. 1. (a) Shock wave permeabilisation equipment and setup.
fitted above the shock wave source. Cell samples were supporte
mostatic heater. The flow degasser reduced oxygen content to 1–
transfection. The dimensions of the agar 1 cells containment
oxygenwater-filled tank with a low-density polyethylene
membrane for shock waves to enter, which was coupled
to the shock wave transducer by a thin layer of silicone
oil. Cell samples were suspended underwater (Fig. 1a)
and positioned centrally in the focus through fluoroscopic
projections at 0 and 30 relative to the vertical axis.
Ideal experimental conditions for cells were created
by heating the tank water to 37C using a Grant GD100
water heater (Grant Instruments, Royston, UK). For
experimental reproducibility, as well as in view of a
lack of cavitation nuclei in non-gas-bearing body tissues,
the water was degassed using a pinhole degasser for a
minimum of 1 h.
Shock wave field characterisation
To determine the pressure at the focal point, the acous-
tic field was measured using aM€uller-Platte polyvinylidene
fluoride needle hydrophone (Article No. 100-100-1, M€uller
Instruments, Oberursel, Germany) with a 40-ns rise time.
The signals produced by the hydrophone were recorded
using a digital oscilloscope (Le Croy waveRunner 44 Xi,
400-MHz sampling rate, LeCroy, Santa Clara, CA, USA).
The hydrophone was positioned using a manual three-axis
linear stage. Measurements were taken along the lateral
axes (x and y) in the focal region area, in increments of
1 mm for up to 10 mm, and along the propagation axis (z)
in increments of 2–5 mm for up to 45 mm. Five waveforms
were recorded at each location and converted to pressure
using the calibration furnished by the manufacturer. The
procedure was repeated with the hydrophone inside a vial
only at the focal point.
Sample preparation and treatments
Polypropylene vials (T7813, Sigma-Aldrich) with a
volume of 2 mL were filled with the suspended cells at aShock waves were generated through a 43-L water tank,
d by a sample holder, and maintained at 37C with a ther-
3 mg/L. (b) Custom-made tissue phantom vessel for RNA
were 10 3 5 3 40 mm (L 3W 3 H). DO 5 dissolved
.
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air in the vials. Prepared vials were immediately chilled
and maintained in an ice box throughout the experiment,
except during treatment. This prevented the occurrence of
the temperature-dependent endocytosis process during
sample and experiment preparations (Khalil et al.
2006). For every independent cell viability experiment,
shams were prepared alongside the treated samples.
Shams captured the effect of the heated water because
they were placed inside the tank for the duration of the
average shock wave treatment, but were not subjected
to shock wave impulses. Sample vials were treated to a
combination of shock wave parameter variations: number
(125, 250, 500, 1000), energy level (3, 6, 9) and pulse
repetition frequency (PRF; 1, 2 Hz). All experiments
were performed with the wide focal zone of the
lithotripter.
mRNA and siRNA stability
Sterilised vials were filled with 1 mg/mL eGFP
mRNA (StemMACS, Miltenyi Biotec, Woking, UK) in
serum-free RPMI-1640 medium, in the absence of cells,
and exposed to shock waves. The rabbit reticulocyte lysate
cell-free gene expression system (Nuclease Treated
L4960, Promega, Madison, WI, USA) was utilised to
assess mRNA translation activity after shock wave treat-
ment. The translation reaction was prepared in accordance
with the supplier’s protocol. Constituent volumes were
adapted to the mRNA concentration as well as to permit
microplate fluorometric reading, while maintaining
relative proportions. A control mixture not containing
any mRNA was also prepared to measure background
from the rabbit reticulocyte lysate. The reactions were
incubated at 37C for 75 min. Fluorometry was then
performed at 485-nm excitation and 520-nm emission.
Electrophoresis-based nucleic acid structural
integrity post-shock waves was tested. Enhanced GFP
(eGFP) siRNA (Silencer, Thermo Fisher Scientific) and
eGFP mRNA cell-free samples were prepared at 15 and
2.5 mg/mL, respectively, in UltraPure DNAse/RNAse-
free distilled water (Thermo Fisher Scientific). For
siRNA analysis, traditional 1% agarose gel electropho-
resis in 13 Tris–borate–EDTA buffer was performed.
For mRNA analysis, the Agilent 2100 Bioanalyzer
(Agilent Technologies, Palo Alto, USA) and RNA 6000
pico kit (due to low concentrated mRNA samples) were
employed. The assay was conducted according to the
Agilent guide for the required kit. RNaseZAP cleaning
agent (R2020, Sigma-Aldrich) was applied to all
equipment at the start of the procedure.
Cell survival and viability assay
Cell viability of cells was tested with the MTS
assay (CellTiter 96 AQueous One Solution Cell ProliferationAssay [3-(4,5-dimethylthiazol-2-yl)-5-
(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tet-
razolium], Promega). After exposure, 200 mL of cell
suspension from each vial was plated into a 96-well
plate at two wells per vial. The procedure was repeated
for a second 96-well plate. Twenty microliters of MTS
solution was added to each well of the first well plate
and incubated for 30 min, representing the 1-h-post-
exposure assay; the second well plate was incubated
with the MTS after 24 h of incubation post-exposure.
Absorbance was read at 490 nm (1.0-s measurement
time) using a Wallac 1420 Victor2 microplate reader
(Perkin Elmer, Beaconsfield, UK).
Cell permeabilisation analysis
Membrane permeabilisation analyses were carried
out using a Becton Dickinson FACSCalibur flow cytome-
ter (BD Biosciences, Franklin Lakes, NJ, USA). Five
hundred microliters of cell suspension from each vial
was transferred into tubes, maintaining cells in a chilled
environment. A solution of 6 mg/mL propidium iodide
(PI, Sigma-Aldrich) was prepared. One hundred microli-
ters of the solution was added to each tube, which was
briefly vortexed immediately before analysis. An argon
laser provided excitation at 488 nm. The software
programme CellQuest Pro (BD Biosciences) was used to
acquire and analyse thedata.Ten thousand cells per sample
were recorded and sorted by gating in two ways: (i) for-
ward scatter/side scatter to identify viable cells, and (ii)
PI staining to identify molecule-internalised cells. Data
acquisition was initialised with the negative control sam-
ples, followed by all other samples in the absence of PI.
The percentage of PI-positive cells was obtained by setting
a gate in the PI fluorescence intensity frequency histogram
of sham samples above which circa 0.1% of cells fell.
Transfection procedure
Green fluorescent protein production and knock-
down were tested using eGFP mRNA and eGFP siRNA
respectively. This reporter gene was selected because of
its inherent stability, allowing its accumulation and easy
detection in living cells (Li et al. 1998). CT26 cells at a
density of 2.53 106/mLwere employed for mRNA trans-
fection experiments, whereas MCF-7/GFP cells at
1.5 3 106/mL were employed for siRNA transfections.
Cells were immobilised in 1% w/v agar in a 2-mL
custom-made tissue phantom vessel (Fig. 1b) and
supplied with 5 mg mRNA or 10 mg siRNA in UltraPure
DNAse/RNAse-free distilled water, before shock wave
treatment. For the siRNA transfections, both the agar
and the cells were prepared in Opti-MEM Reduced
Serum Medium (Thermo Fisher Scientific) before
mixing, whereas for mRNA transfections, cells
and agar were prepared in RPMI-1640 medium and
2482 Ultrasound in Medicine and Biology Volume 42, Number 10, 2016phosphate-buffered saline, respectively. Transfection
shams consisted of samples supplied with the nucleotide
of interest, but not exposed to any shock wave pulses.
Afterward, vessels were maintained at 37C in cell
culture incubators and removed only for analyses.
Transfections were assayed by fluorometry using the
FLUOstar Omega microplate reader (BMG Labtech,
Ortenberg, Germany). For mRNA transfection, fluores-
cence intensity (FI) was read 24 and 48 h after shock
wave treatment to allow all potential cells to synthesise
and express the GFP. Similarly, siRNA-mediated knock-
downwas assayed at 24, 48 and 72 h, a time frame defined
to capture the translational arrest subsequent to target
mRNA degradation. Fluorescence was visualised at the
respective final assay time point using the Nikon Eclipse
TiE2000 inverted microscope (Nikon, Tokyo, Japan) with
a 103 objective lens; microscopic views within the upper
agar region of the tissue phantom vessel were generated
using NIS-Elements AR software (Nikon).
Similarly, shock wave-induced dissemination of the
nucleotides across the TMMwas characterised by using a
eGFP mRNA analogue, fluorescein isothiocyanate-
dextran (FITC-D; FD250 S, Sigma Aldrich), at a
molecular weight of 250 kDa, to simulate as closely
as possible the size of the eGFP mRNA (1000
nucleotides 5 320 kDa). FITC-D was employed to
determine immediate macromolecule dispersion (through0 125 250 500
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Fig. 2. Influence of shock wave exposure on cell viability. CT2
MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphen
ence of number of shock waves, energy and pulse repetition
mean values of three same-day replicates per treatment, for at
bars are standaspatial green fluorescence measurements), thus distin-
guishing shock wave-induced delivery from passive
diffusion, which is time driven. A range of FITC-D
amounts were tested, consisting of the mRNA dose
applied in transfection, the average in vitro 20- to 30-mg
transferred DNA amounts reported in the literature
(Miller et al. 1999; Lauer et al. 1997) and a
proportionally scaled up dose.RESULTS
Influence of shock wave parameters on CT26 cell
viability and permeabilisation
Expression of delivered transgenes is possible only
where live cells exist. Cell response to shock waves is
dependent on several factors including SW parameters,
the physical environment of cells and the cell type. Shock
waves can result in enhanced proliferation (Weihs et al.
2014), or marked cytotoxicity (Br€ummer et al. 1989;
Gambihler et al. 1990; Miller et al. 1999). Thus, shock
wave-induced cytotoxicity was investigated to identify
a parameter space that maximised cell viability.
Figure 2 illustrates a shock wave dose-dependent
decrease in the viability of CT26 cells 1 h after exposure.
This effect was greater with increasing energy level and
number of shock waves, where 500 pulses at the highest
attainable energy level (9 E) amounted to a viability of0 125 250 500
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k waves 
0 125 250 500
50
100
150
24 Hrs, 3 E, 1 Hz
24 Hrs, 6 E, 1 Hz
24 Hrs, 9 E, 1 Hz
24 Hrs, 3 E, 2 Hz
24 Hrs, 6 E, 2 Hz
24 Hrs, 9 E, 2 Hz
24 Hours
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frequency was investigated. Data points represent the
least three separate-day experiments (i.e., n 5 9). Error
rd errors.
Fig. 3. Flow cytometric measurements of CT26 cell permeabi-
lisation and viability. Cell permeabilisation was assessed
through propidium iodide (PI) fluorescence-assisted cell sorting
(using the FL2-H channel for PI fluorochrome detection), and
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the overall pattern of this loss of viability. At 24 h, MTS
assays were performed again, and comparison with 1-h
data allowed the recovery of cells to be characterised.
The 24-h viabilities were comparably elevated in the
majority of cases, indicating a population growth phase
at or within 24 h. However, the extent of growth differed
between treatments as well as within treatment replicates,
with some treatments (e.g., 3 E, 250 pulses, 2 Hz)
suggesting metabolic activity within the wells was
doubling between the 1- and 24-h readings; other
treatments (e.g., 9 E, 500, 2 Hz) causedminimal sustained
depletion of viability, implying that under those condi-
tions, shock waves instigated damage from which the
cells could not recover. The shock wave stimulative effect
at low energy was evidenced at both PRFs in the 24-h
assay; a wider range of energies displayed this effect at
1 Hz, whereas proliferation peaked at 2 Hz.
The impact of shock waves on cell viability was
probed further using flow cytometry (recall methods).
Figure 3 provides example distributions for a sham-
treated population (a), a minimally exposed (3 E, 125
shocks, 2 Hz) population (b) and a maximally exposed
(9 E, 500 shocks, 2 Hz) population (c). Based on the un-
treated (sham) cells, subpopulations such as fragmented
cells and cellular debris were identified by side scatter
(SSC), which is proportional to cell granularity. Cell
permeabilisation, as characterised by cell staining with
PI immediately after shock wave exposure, was
quantified by the fluorescence gate separating the
SSC/FL2-H plots into left and right halves, as illustrated
in Figure 3 (where FL2 is a channel for the detection of
emission wavelengths comprising the emission peak of
PI). Events in the right half represented the proportion
of total PI-positive cells, which is seen to increase with
increasing shock wave parameter.
The minimum SSC of the untreated population pro-
vided a baseline for an additional gate to separate intact
from damaged cells, where the first quadrant identifies
the population of whole and permeabilised cells. Note
that less than 4% of cells were intact and PI-positive in
the sham samples, suggesting that a small proportion of
cells became compromised by the removal of
culture conditions. Reversible damage (i.e., transiently
permeabilised cells) was determined by correlating totalviability was analysed through forward (FSC) and side (SSC)
scatter. Density plots illustrate representative cell populations
for three treatments: sham (a); 3 E, 125 pulses, 2 Hz (b); 9 E,
500 pulses, 2 Hz (c). The fluorescence-based quadrant gates
(purple lines) were set to identify the percentage of PI-
positive intact events. The data are representative of nine
repeats.
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parameter space defined by 9 E, 125, 2 Hz and 3 E,
500, 2 Hz was found that permitted temporal membrane
permeabilisation to the PI of up to 15%, without any
associated cell death (Fig. 4). For almost all shock
wave conditions, results revealed an inverse correlation
between the percentage of permeabilised cells and
viability.
The influence of PRF on cell viability was further
investigated, to a maximum of 4 Hz, which could only
be realised for energy levels 3 and 9 (data not shown)
because of the capacitance of the shock wave source.
For a fixed number of shock waves (250), while varying
the PRF in increments of 1 Hz, no statistical significance
was found between PRFs in both energy level sets
(p 5 0.8 and 0.49 for the 3 E and 6 E sets, respectively).
Thus, it was thought that for any two treatments where
only the PRF was the varying parameter, any difference
in apparent viability was due to changes in cell
morphology (i.e., cell injury) rather than cell destruction,
because of PRF-effectuated cell accelerations and/or
collisions.
Optimisation of shock wave parameters
The shock wave settings that imparted the maximum
number of permeabilised (as detected by PI staining) but
still viable (as detected by MTS) cells was sought. This
value may be considered the ‘‘transfectable’’ population.
Although all killed cells are permeabilised, not all
permeabilised cells are killed. A 2-D interpolation
of CT26 cell permeabilisation and 24-h viability wasperformed between data points, in increments that related
to attainable lithotripter settings, and the proportions of
permeabilised cells above the proportions of non-viable
cells were derived. Figure 5 illustrates the resulting
contours of high and low transfection power across shock
wave energies and numbers of pulses. The highest value
is seen to be produced by 548 shock waves, at 4.5 E (see
white arrow), where 20.19% of total cells are theoreti-
cally capable of being transfected in the presence of a
nucleic acid, whilst maintaining 24-h cell survival rates
at 100%. To confirm this effect, the optimum shock
wave setting was experimentally tested, and a reversible
cell permeabilisation of 20.5 6 2.7% was found.
Karshafian et al. (2009) optimised their ultrasound
exposure system by deriving a similar measure that
compared the desired and destructive effects of any given
shock wave condition.
Notably, Figure 5 also illustrates that at the highest
energies and circa 150 pulses (see black arrow), there is
a local increase in the percentage of live permeabilised
cells, suggesting that a regime consisting of a few shock
waves at high peak pressures may exist where appreciable
cell permeabilisation is attained.Shock wave pressure
In Figure 6(a) are pressure waveforms measured at
the focus of the lithotripter at the optimal energy level
for CT26 cells, in degassed water and with the needle
hydrophone in the polypropylene vial. The presence of
the vial decreased the peak positive pressure by 57%
and increased the duration of the compressive phase
from 2.57 to 4.63 ms, which was measured from the
Fig. 6. (a) Representative shock waveform at energy level 4.5 when measured at the focal point in degassed water and
inside the polypropylene vial. (b) Measurements of peak positive pressure at energy level 4.5, in the direction perpendic-
ular to the shock wave propagation path (x–y) and along the path (z). Error bars are standard deviations (range: 0.07–
0.86 MPa). The focal zone is marked by the dashed line representing the pressure being 6 dB less than the maximum
peak positive pressure.
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itive pressure, up to the first time the positive pressure
decreases below 10% of the peak positive pressure
(International Electrotechnical Commission 1998).
The negative pressure did not change substantially, as
evidenced by a 1.3-MPa decrease when inside the vial,
either as a result of the limiting hydrophone’s
susceptibility to damage, stemming from cavitation
during the negative phase (Smith et al. 2012), or because
the negative phase is more sensitive to the
low-frequency components of the signal and thus less
affected by the vial. Moreover, the presence of the vial
did not appreciably change the shape of the waveform.
At the focal point, the peak pressures for energy levels
3, 4.5, 6 and 9 are given in Table 1.
The variation in peak positive pressure in the focal
zone of the lithotripter at energy level 4.5 was also
measured. Figure 6(b) illustrates peak pressure in the
lateral plane (x, y) and along the propagation path (z).
The maximum error in hydrophone positioning was a
standard deviation of 0.86 MPa. In the lateral direction
the pressure amplitude dropped to 50% as demarcated
by the 26-dB threshold line, at a radial distance of
3.9 mm, whereas in the axial direction, the 26-dB focal
zone was asymmetric about the focus and spannedTable 1. Shock wave focal pressure
Energy level Peak positive (MPa) Peak negative (MPa)
3 E 8.6 6 0.3 4.7 6 0.3
4.5 E 14.9 6 0.2 5.0 6 0.1
6 E 20.7 6 0.8 6.4 6 0.4
9 E 37.0 6 0.5 7.2 6 0.542.4 mm. Therefore, the incident pressure field was
relatively uniform within the exposure vessels (vial and
TMM were 9 or 10 mm wide and 40 mm long), although
the vessel material is likely to have resulted in some
variation.
Permeabilisation and viability of HK-2 and
MCF-7/GFP cells
The impact of shock waves on other cell lines was
investigated using HK-2 and MCF-7 cells to gauge vari-
ability across different cell types. Cell permeabilisation
and viability data were processed similarly to data from
CT26 cells. Appropriate settings for the flow cytometer’s
detectors and amplifiers were adjusted accordingly.
However, for MCF-7/GFP cells, PI positivity was
detected using the FL3 channel because of the GFP signal
bleeding into the FL2 channel. The overlap between FL2
and FL3 detectors at 620 nm enabled PI detection in
either channel.
The cell viabilities of HK-2 cells were shock wave
dose dependent, with values ranging from 70% to
129% relative to sham controls. In contrast, the
permeabilisation of HK-2 cells (Fig. 7) revealed little
correlation with shock wave parameters. However, a
measurable level of shock wave-induced permeabilisa-
tion was observed, highlighting the sensitivity of the
cell line to ultrasound. Given that HK-2 cells are
transformed, rather than of cancer origin, provides
evidence of shock wave applicability in non-cancerous
gene therapy applications.
Results of MCF-7/GFP permeabilisation, illustrated
in Figure 7, confirmed the differential effect of shock
waves on cancer cells, previously observed with
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Fig. 7. Influence of shock wave exposure on HK-2 and MCF-7/GFP cell permeabilisation (bars) and 24-h-post-exposure
cell viability (lines). Data points represent the mean values of three same-day replicates per treatment, for three separate-
day experiments (i.e., n5 9). Error bars are standard deviations. HK-25 immortalised human proximal tubule epithelial
cells; MCF-7/GFP 5 human breast cancer cells stably expressing green fluorescent protein; PI 5 propidium iodide.
2486 Ultrasound in Medicine and Biology Volume 42, Number 10, 2016CT26 cells, where both shock wave energy and
number of pulses were effective discriminants. However,
the cell line revealed reduced amenability to be
efficiently transfected as the highest proportion of
permeabilised cells above that of killed cells was
found to be 4.1% by exposure to 134 shock waves,
energy level 5.0, at 2 Hz. Although up to 23.5% of cells
could be permeabilised (500 shocks, 9 E), these
parameters were associated with a 25% loss in viability.
This is consistent with reports that have described
MCF-7 cells as ‘‘hard to transfect’’ in the literature
(Fire et al. 2005).Fig. 8. Results of stability post shock wave exposure for (a) mR
stability data depict (a-1) representative mRNA electrophoreti
analysis (based on n5 3), and (a-2) mRNA biological activity d
pendently conducted experiments (n 5 3). Error bars repres
siRNA 5 small interfering RNRNA stability
Having identified shock wave parameters that would
allow transfection whilst maintaining cell viability, the
effect of shock waves on the stability of nucleotide was
tested. The structural stabilities of mRNA and siRNA
were determined using the Bioanalyzer and traditional
gel electrophoresis respectively. Figure 8(a-1) depicts
representative electropherograms of sham and optimum
shock wave treated mRNA. The distinct 18 S and 28 S
ribosomal peaks of typical RNA were present in both
treatments. No shift in nucleotide (nt) size of both peaks
was observed with optimal shock wave exposure. InNA and (b) siRNA, compared to sham controls. Structural
c profiles and (b) agarose gel electrophoresis for siRNA
ata consisting of one sample per treatment, for three inde-
ent the standard deviations. FU 5 fluorescence units;
A; SW 5 shock wave.
Lithotripter shock waves for RNA nucleotide delivery d S. NWOKEOHA et al. 2487addition, the absence of smaller peaks between the two
ribosomal peaks (typically observed in partially digested
RNA) suggested that the structure-based functionality of
the exposed mRNA had not been impaired. However, a
22% decrease in the 28 S ribosomal peak intensity was
detected with shock wave exposure (1765 6 183 pg/mL
for the shams vs. 1363 6 115 pg/mL for the shock wave
treated, based on n 5 3). On the stability of siRNA,
Figure 8(b) illustrates that optimal shock waves for
MCF-7/GFP cells did not substantially affect the
structure or concentration of siRNA, with comparably
equal migration and similar fluorescence intensity of
the bands with respect to the non-shocked siRNA.
Maintenance of mRNA biological stability was as-
sayed by performing cell-free protein translations of the
GFP mRNA transcript, allowing for absolute measure-
ments of shock wave-induced damage to the activity of
the mRNA, as there was no cell interference during expo-
sure. Figure 8(a-2) illustrates the translational activity of
sham controls and optimum shock wave-treated samples,
in terms of GFP fluorescence intensity. An 18% drop in
mean fluorescence intensity was observed between
sham and optimum shock waves (167,570 vs. 137,125
fluorescence units, respectively) which was not found to
be statistically significant. Thus, results from both stabil-
ity methods were in agreement on the effects impacted
onto the mRNA by shock waves. Though there are no pre-
vious direct investigations of the (in)stability of mRNA in
acoustic fields, Forbrich et al. (2013) reported ultrasound-
enhanced cellular liberation of endogenous mRNA. They
determined significant numbers of liberated mRNA
molecules, as assayed by reverse transcription and
quantitative polymerase chain reaction, thus entailing
functional post-exposure mRNA. Furthermore, although
ultrasound-assisted delivery of complexed mRNA has
been reported (De Temmerman et al. 2011), no
comparison can be made between free and complexed
mRNA.
Ultimately, the reported reduction in RNA quality
caused by shock waves was found to be slight and
non-significant compared with the potential for enhanced
nucleotide delivery.
Shock wave-mediated dissemination of 250-kDa FITC-D
in agar is a function of macromolecule availability
The application of shock waves has the added po-
tential to improve the transfer of nucleotide from blood
vessels and into target tissue. Having identified shock
wave exposure conditions that were conducive to cell
viability and maintenance of nucleotide structure, the
impact of these conditions on mass transfer out of a
model channel and into the TMM was investigated.
Using the custom-made tissue phantom vessels (see
Fig. 1b), FITC-D was loaded into the vessel (0 mm),exposed to shock waves from beneath and transfer
toward the shock wave source (up to 220 mm) or
away from the shock wave source (up to 120 mm)
was measured.
Figure 9 depicts results of scaled fluorescence
against distance below (22.5 to 220 mm) and above
(2.5 to 20 mm) the channel. The channel is illustratively
demarcated by the dash-dot lines. At all three dextran
amounts (red line), there was an elevated fluorescence
signal in the upper agar region (between 12.5 mm
and 120 mm) in the presence of shock waves, as
compared with the sham treated samples (blue line).
At the farthest distance (20 mm), scaled intensities
were  6-, 8- and 25-fold higher than corresponding
sham intensities at 5, 30 and 180 mg FITC-D respectively.
Contrast between shams revealed some degree of passive
dissemination into the agar from the channel, where
increasing dextran mass increased the fluorescence in
the vicinity of the channel.
GFP mRNA transfection
Experiments were performed to investigate if cells
embedded in TMM could produce transgene from nucle-
otide delivered through a channel compartment within
the TMM. Cells were transfected with eGFP mRNA in
the absence and presence of the optimal shock waves
and incubated for periods of 24 and 48 h. For fluorescence
reading, the 40 3 10 3 5-mm Mylar window was
discretised into 13 13 5-mm volumes, and fluorescence
values were recorded for each. Due to cell growth and/or
migration, the calculated mean FIs included the channel
regions as well. Figure 10(a) illustrates the levels of
GFP expression at the two time points for both sample
treatments. The fluorescence of no-treatment samples
comprising only cells was subtracted from the recorded
FIs of the shock wave- and sham-treated samples. For a
given independently conducted experiment, the FI
variance between replicates was generally higher at
24 h than at 48 h, which was thought to be due to time
differences in the onset of protein synthesis. Low
numbers of successfully transferred nucleic acids have
been previously attributed to the often observed
stochasticity in gene expression (Schwake et al. 2010).
At 24 h after shock wave exposure or sham treat-
ment, the FI of shock wave-treated cells, compared
with shams was substantially 6-fold higher. When cells
were incubated for a further 24 h, an 52-fold increase
(p , 0.05) in FI was evident for the shock wave-treated
cells. FI levels could not be correlated with the number
of GFP-positive cells, because of the multiplanar
presence of cells in deep tissue phantom samples, as
well as the GFP spatial heterogeneity observed
microscopically (see Fig. 10b). The images represent
835.2 3 624-mm areas (0.6 mm/px at 1392 3 1040),
Fig. 9. Representative disseminations of 250-kDa fluorescein isothiocyanate (FITC)-dextran within the TMM, along the
direction of shock wave propagation (i.e., from220 to 20 mm) after shock wave or sham treatment. The areas in-between
the dash-dot lines represent the channel width. The black arrow indicates the direction of shock wave propagation.
2488 Ultrasound in Medicine and Biology Volume 42, Number 10, 2016depicting intensely green fluorescent cells when exposed
to the optimum shock waves. In contrast, little GFP signal
could be detected microscopically in the sham samples.
RNA transfection promotes transient gene expression;
hence, strongly expressing cells are desirable to produce
sufficient therapeutic benefit.
GFP siRNA transfection
In addition to providing production of therapeutic
protein, the tissue-mimicking phantom developed here
was tested to see if the delivery of siRNA could be
achieved to provide knockdown of a GFP reporter gene.
An initial assessment was performed on fluorescence
quantification for four MCF-7/GFP concentrations over
a 4 log range, and a linear relationship was found between
FI and cell concentration, indicating the ability of the
quantification method to detect small changes in the num-
ber of fluorescent cells.
Results of shock wave–mediated GFP knockdown
are illustrated in Figure 11(a). For siRNA delivery, the
optimal shock waves for MCF-7/GFP cells were
delivered to samples. Three forms of negative control
were tested: (i) gene knockdown specificity (using
scrambled siRNA whose sequence is intentionallynon-complementary to that of the mRNA encoding
GFP); (ii) sham treatment; and (iii) no treatment (absence
of both GFP siRNA and shock wave exposure). An
additional no-treatment control based on non-GFP
MCF-7 cells was tested to distinguish between GFP and
autofluorescence detection. For all samples, the region
of analysis was restricted to the agar area 5 mm above
the channel, in which a differential effect between
treatments was observed.
Comparisons of relative fluorescence between treat-
ment groups using one-way analysis of variance revealed
statistical significance at all three time points (p, 0.05).
Themaximum depletion of GFP signal occurred at 48 h in
cells exposed to siRNA and shock waves. This result was
17% higher than that for sham controls. The largest dif-
ference in GFP fluorescence (23%) between sham and
siRNA 1 shock waves was recorded at 72 h.
Figure 11(b) compares the spatial fluorescence across
the TMM between siRNA/1 SWs and sham siRNA.
GFP reduction was also observed in all three negative
controls with a peak loss of5% relative to sham, occur-
ring in the scrambled siRNA1 SWs samples, implying a
small percentage of shock wave-induced cell death at
72 h. The FI decrease over time was generally invariable
Fig. 10. Results of enhanced green fluorescent protein mRNA delivery to CT26 cells for shock wave- and sham-treated
samples. (a) Data are expressed as the means of intensities of six replicates per sample across two independently conduct-
ed experiments. Error bars are standard deviations. Significance was tested using the two-tailed unpaired parametric t-test
where *p, 0.05 (p5 0.04). (b) Representative images of green fluorescent protein expression at 48 h after sham or shock
wave treatment. Images were converted to binary by thresholding.
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toxicity to affect MCF-7 cells exposed to the TMM
in vitro system for over 24 h. Furthermore, at 72 h, an in-
crease in fluorescence was observed in all groups, but
particularly in the nucleotide-containing treatments.
Two possible reasons for the slight fluorescence recovery
are as follows: (i) non-GFPMCF-7 cells (data not shown)
revealed an upward trend in cellular fluorescence with
increasing time, to a maximum of 12% relative to the
initial (background) fluorescence read at 0 h. Such auto-
fluorescence, which is indicative of cell necrosis and
increases with decreasing metabolic activity, may have
explained the upturn of fluorescence at 72 h. (ii) Cell
proliferation up to 72 h was likely to have produced the
increased GFP signal because of an increase in the num-
ber of cells. In the case of the siRNA1 SW treatment, the
net increase in fluorescence was due to a concurrent loss
of siRNA function resulting from its degradation (of
which 72 h defines a time well beyond its onset, consid-
ering siRNA’s half-life of 24 h [Bartlett and Davis 2006]).
Post hoc pairwise comparisons using the Tukey range
test did not prove statistical significance for scrambledsiRNAor no-treatment results, comparedwith sham siRNA,
at any time point analysed. However, significant differences
were detected between siRNA 1 SWs and sham siRNA:
q 5 7.08 .q(crit 5 6.35), q 5 17.12 .q(crit 5 13.67),
q 5 23.2 .q(crit 5 19.8) at 24, 48 and 72 h respectively].
At 48 h, the difference between the two shock wave (1SW)
groups was found to be significant, signifying treatment
specificity as well as enabling separation of the proportion
of siRNA silenced GFP cells from those collaterally
silenced as a result of shock wave-induced damage.DISCUSSION
Externally applied ultrasound offers an increasingly
popular approach to tackling the challenge of gene
delivery (Carlisle et al. 2013). Shock wave exposure
may be particularly attractive in certain situations
because it is comparatively low cost, clinically available
and has a safety track record through lithotripsy. The
presented studies indicated that exposure of cancer cell
lines in vitro to lithotripter shock waves, using clinically
Fig. 11. Results of anti-eGFP siRNA delivery to MCF-7/GFP cells. (a) GFP intensities of shock wave treated (1SW) and
non-treated (2SW) samples consisting of three replicates per sample for one independently conducted experiment, up to
3 d after sample preparation or treatment. Data are expressed as the percentage fluorescence relative to initial fluores-
cence. Error bars are standard deviations. Significance was tested using one-way analysis of variance and post hoc Tukey
range tests. The latter revealed statistical significance, denoted by the asterisks: *between siRNA1 SWand sham; **be-
tween siRNA1 SWand scR1 SW, in addition to (*). (b) Representative spatial fluorescence intensities across the TMM
region of interest for SWand sham siRNA treatments; the dashed lines demarcate the siRNA-incorporated channel. The
black arrow represents the direction of SW propagation. eGFP5 enhanced green fluorescent protein; FI5 fluorescence
intensity; siRNA 5 small interfering RNA; scR 5 scrambled RNA; TMM 5 tissue-mimicking material.
2490 Ultrasound in Medicine and Biology Volume 42, Number 10, 2016available parameter settings, resulted in differential cell
viability and reversible membrane permeabilisation.
In the mouse colorectal carcinoma cell line, the ac-
quired cell viability data revealed high statistical power
(p , 0.01) between 125, 250 and 500 pulse number
sets (encompassing the various energy levels and PRFs
tested). In fact, microscopic examination revealed that
doubling the number of pulses produced progressively
shrunken cells in the presence of some cellular debris.
In human breast cancer cells, comparably more irrevers-
ible permeabilisation was noted, as reflected by the poor
recovery of viability at 24 h (Fig. 7b).
A study by Guck et al. (2005) on the elasticity of
MCF-7 cells, based on an optical stretching technique,
revealed an approximate 10% increase in peak
deformability compared with other malignant cells. We
speculate that the lower elasticity of MCF-7 cells resulted
in greater deformation when subjected to shock waves,
hence producing greater damage and permeabilisation.
On the other hand, cell viability data for the transformed
non-cancerous human kidney cells revealed a sensitivity
to shock waves comparable to that of CT26 cells.
Br€ummer et al. (1990) made a similar conclusion
regarding malignant and normal cells as they found no
significant difference in their median lethal dose (LD50)
values. Although HK-2 manifests both normal and
cancerous cell characteristics, these non-malignant cells
further agreed with the non-distinguishing dose effectof normal cells observed by Br€ummer et al. (1990)
because uniquely high cell permeabilisation levels could
not be established.
Shock wave parametric studies were conducted to
determine the settings that maximised cell permeabilisa-
tion with no effect on the viability. The optimal number of
pulses for MCF-7 cells was four times less than the
number required for CT26 cells, whereas the similarity
in optimal shock wave energy indicated the presence of
an energy threshold belowwhich reversible permeabilisa-
tion is negligible.
Sonoporation is a process of temporary benefit, as
the cell membrane naturally re-forms afterward if the
cell remains viable. The time taken for such repair has
not been defined for most cell lines, and there are few
data concerning the differences between cancer cell lines
and primary cells. The ability of transiently defected cells
to permit PI entry was characterised as a measure of per-
meabilisation. PI is a nuclear stain that is detected upon
binding to cellular DNA. Therefore, PI is a late marker
in the context of plasma membrane permeability and ex-
cludes the population of cells whose nuclear membrane is
intact but whose plasma membrane is compromised. It
follows that our reversible plasma membrane permeabili-
sation results of 20.5% and 4.1% for CT26 and
MCF-7 cells, respectively, are underestimates of the
proportion of potentially RNA transfectable cells, as
these require only perturbation of the plasma membrane.
Lithotripter shock waves for RNA nucleotide delivery d S. NWOKEOHA et al. 2491Results comparable to those for CT26 transfectability
have been obtained using therapeutic ultrasound (centre
frequencies of 1–5 MHz) and variable intensity levels,
where 28% (Duvshani-Eshet et al. 2005) and 32%
(Karshafian et al. 2009) transfected or transfectable cells,
respectively, have been reported per total number of cells.
However, the latter was attained in the presence of
ultrasound contrast agents to function as nuclei for
cavitation. Our shock wave-mediated transfection
required no nucleation agents.
Experiments were designed by considering a num-
ber of aspects that would affect shock wave propagation
to the cells and gene delivery efficiency. First, the shock
wave-induced cell streaming in fluid at low cell concen-
trations and subsequent reduced bio-effects inspired the
development of TMM exposure vessels (Fig. 1b) that
permitted the analysis of immobilised cells without
needing to dislodge them. Cells embedded in agar al-
lowed shock wave forces to act directly on the cells,
thus more likely reflecting the transfection levels that
may be observed in tissue, than experiments using iso-
lated cells in solution. Second, preliminary transfection
tests revealed that the cell or nucleotide concentrations
were not as important as the cell-to-RNA ratio (data not
shown). A supporting study by Bao et al. (1998) scaled
up in vitromRNA dose for in vivo use and obtained lower
transfection efficiencies in vivo than they had in vitro,
probably because the assumed cell-to-mRNA ratio may
not have applied to both conditions. In our transfections,
the lowest nucleotide concentrations that produced a
measurable and distinguishable transfection effect be-
tween treatments were employed. At an equivalent dose
(i.e., 5 mg), RNA-like penetration in 1% agar with optimal
shock waves resulted in a maximum distance travelled of
approximately 10 mm above the channel, whereas greater
depths were attained with increasing availability of the
macromolecule (Fig. 9). However, the study was limited
by FITC-D emissions in areas where GFP mRNA expres-
sion cannot take place, such as on cell membranes.
In this work in vitro transfections were performed in
a new tissue-mimicking model, that is, not suspended in
cell culture or growth medium, but having compartmen-
talised RNA and cells, in an effort to simulate nucleic
acid administration via the bloodstream. As such, the
efficiency of gene delivery could not be assessed in a
single-cell fashion, and thus, the number of transfected
cells is not given. Notably, this SW exposure system
allowed us to report considerable mediation in gene
augmentation and gene knockdown with optimal
lithotripter shock wave treatment, compared with sham
treatment. In comparison to the similarly low concentra-
tions of nucleotide (plasmid DNA) administered (1–5 mg
in 106 cells), Huber et al. (1999) reported that only 800 of
one million cells were successfully transfected, whereasMurata et al. (2007) reported a less than twofold increase
in luciferase expression, relative to control with shock
wave application. In this first study, to our knowledge,
of shock wave-assisted mRNA delivery, an enhancement
greater than 50-fold was attained. Furthermore, siRNA
transfection was enhanced with optimal shock wave
exposure despite being challenged by the cell line’s
relatively low amenability to delivery, with a twofold
increase in knockdown relative to sham siRNA at 72 h be-
ing achieved. Similarly, Ha et al. (2015) transfected
CT26 cells with anti-GAPDH siRNA through low energy
shock wave exposure and obtained an approximately
threefold decrease in the relative GAPDH expression
compared with controls in an in vitro setup comprising
a shock wave probe immersed in cell suspensions. In
the presence of microbubble contrast agents and unfo-
cused ultrasound in lieu of shock waves, Juffermans
et al. (2014) reported an approximately fourfold decrease
in GAPDH expression.CONCLUSIONS
We found that shock wave exposure can successfully
induce RNA transfer into cells without imparting cellular
or nucleic acid damage and that this may be possible in a
broad range of tissue types by tuning the shock wave
exposure parameters. These effects were accomplished
using a clinical electromagnetic lithotripter, which pro-
vides a pathway for clinical translation. Variability in
the optimum parameters is expected where different types
of lithotripters (e.g., piezoelectric, electrohydraulic) are
employed, having a dissimilar focal volume and shock
waveform from those in this work. Further research is
to be undertaken to determine how these findings may
affect therapy and its effectiveness.
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